Your new experience awaits. Try the new design now and help us make it even better

RETRACTION article

Front. Mol. Biosci., 28 November 2025

Sec. Molecular Diagnostics and Therapeutics

Volume 12 - 2025 | https://doi.org/10.3389/fmolb.2025.1751510

This article is part of the Research TopicRecent Advances in In Vitro and In Vivo Multi-omics Analyses of Extracellular Vesicles: Therapeutic Targets and BiomarkersView all 8 articles

Retraction: Resveratrol improves mitochondrial biogenesis function and activates PGC-1α pathway in a preclinical model of early brain injury following subarachnoid hemorrhage

This article is a retraction of:

  1. RETRACTED: Resveratrol Improves Mitochondrial Biogenesis Function and Activates PGC-1α Pathway in a Preclinical Model of Early Brain Injury Following Subarachnoid Hemorrhage

    1. Read original article
Frontiers Editorial Office Frontiers Editorial Office*

A Retraction of the Original Research article
Resveratrol improves mitochondrial biogenesis function and activates PGC-1α pathway in a preclinical model of early brain injury following subarachnoid hemorrhage

by Zhou J, Yang Z, Shen R, Zhen H, Zhong W, Chen Z, Tang J, and Zhu J (2021). Front. Mol. Biosci. 8:620683. doi: 10.3389/fmolb.2021.620683

The journal retracts the 22 April 2021 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.

This retraction was approved by the Chief Editors of Frontiers in Molecular Biosciences and the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication has been recorded by the publisher.

Citation: Frontiers Editorial Office (2025) Retraction: Resveratrol improves mitochondrial biogenesis function and activates PGC-1α pathway in a preclinical model of early brain injury following subarachnoid hemorrhage. Front. Mol. Biosci. 12:1751510. doi: 10.3389/fmolb.2025.1751510

Received: 21 November 2025; Accepted: 21 November 2025;
Published: 28 November 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.